You just read:

Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer

News provided by

Innovent Biologics, Inc.

Aug 05, 2019, 20:00 ET